OftalmoCentro, Private Clinic, Porto Alegre, Av. Coronel Lucas de Oliveira, 505/709, 90440-011, Porto Alegre, RS, Brazil.
Department of Ophthalmology and Otolaryngology, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
Int Ophthalmol. 2020 Nov;40(11):2847-2854. doi: 10.1007/s10792-020-01468-4. Epub 2020 Jun 19.
BACKGROUND/AIMS: Intrastromal corneal ring segments (ICRS) have been found to be useful in correcting keratoconus by decreasing irregular astigmatism, thereby potentially improving visual acuity. However, its long-term effects in keratoconus progression are not completely understood, mainly concerning the effects of age on ICRS implantation results. This study aimed to evaluate long-term effects of ICRS implantation according to age at implantation.
We conducted a longitudinal retrospective study, where we evaluated patients with keratoconus who underwent ICRS implantation between 2004 and 2012.
We evaluated 34 eyes for 5 years post-operatively. The mean age of the 21 men and 7 women was 20.59 ± 4.65 years. Best spectacle-corrected visual acuity (BSCVA) improved from 0.32 ± 0.19 in the preoperative period to 0.46 ± 0.27 6 months post-operatively. After up to 5 years of follow-up, there was no significant difference in mean visual acuity of the group. As expected, there was a significant decrease in keratometric values after corneal ring implantation, which remained stable over the 5-year follow-up. Among the 34 cases analysed, nine (26%) showed signs of disease progression. In eight of the nine documented progression cases, patients were 21 years old or younger, revealing that these patients were sevenfold more likely to progress than those aged over 21 years.
In our series of cases, ICRS implantation was shown to be an excellent treatment to reduce corneal curvature and improve visual acuity at all ages, but it did not stabilize the disease, especially in young patients with more aggressive forms of the keratoconus.
背景/目的:间质角膜环段(ICRS)已被证明可通过降低不规则散光来矫正圆锥角膜,从而潜在地提高视力。然而,其在圆锥角膜进展中的长期效果尚不完全清楚,主要涉及年龄对 ICRS 植入结果的影响。本研究旨在根据植入年龄评估 ICRS 植入的长期效果。
我们进行了一项纵向回顾性研究,评估了 2004 年至 2012 年间接受 ICRS 植入术的圆锥角膜患者。
我们对 34 只眼进行了 5 年的术后评估。21 名男性和 7 名女性的平均年龄为 20.59 ± 4.65 岁。最佳矫正视力(BCVA)从术前的 0.32 ± 0.19 提高到术后 6 个月的 0.46 ± 0.27。在长达 5 年的随访后,该组的平均视力没有显著差异。如预期的那样,角膜环植入后角膜屈光度显著下降,并且在 5 年的随访期间保持稳定。在分析的 34 例中,有 9 例(26%)出现疾病进展的迹象。在记录的 9 个进展病例中,有 8 例患者年龄在 21 岁或以下,这表明这些患者进展的可能性是年龄超过 21 岁患者的 7 倍。
在我们的病例系列中,ICRS 植入术被证明是一种极好的治疗方法,可降低角膜曲率并提高所有年龄段的视力,但它并不能稳定疾病,尤其是在具有更侵袭性形式的圆锥角膜的年轻患者中。